Rutgers EJT - Search Results

1

[A woman with a painful swelling in the breast].

Olthof DC, van Urk JJ, Groen EJ, Rutgers EJT, Skinner VP, Winter-Warnars HAO. Olthof DC, et al. Among authors: rutgers ejt. Ned Tijdschr Geneeskd. 2019 May 3;163:D3552. Ned Tijdschr Geneeskd. 2019. PMID: 31120222 Dutch.

2

[A solitary sternal lesion found by skeletal scintigraphy following treatment for breast carcinoma].

Vriens BH, Klaase JM, Schornagel JH, Bartelink H, Rutgers EJ. Vriens BH, et al. Ned Tijdschr Geneeskd. 2007 Sep 1;151(35):1909-14. Ned Tijdschr Geneeskd. 2007. PMID: 17907539 Dutch.

3

[Systematic breast self-examination is not a useful screening procedure, except in hereditary or familial increased risk of breast cancer].

Kaas R, Rutgers EJ. Kaas R, et al. Ned Tijdschr Geneeskd. 2008 Oct 25;152(43):2317-8. Ned Tijdschr Geneeskd. 2008. PMID: 19024059 Dutch.

4

[Guideline 'Treatment of breast cancer 2008' (revision)].

Struikmans H, Nortier JW, Rutgers EJ, Zonderland HM, Bontenbal M, Elkhuizen PH, van Tienhoven G, Tjan-Heijnen VC, van Vegchel T, Tuut MK, Benraadt J. Struikmans H, et al. Ned Tijdschr Geneeskd. 2008 Nov 15;152(46):2507-11. Ned Tijdschr Geneeskd. 2008. PMID: 19055257 Review. Dutch.

5

[Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy].

Straver ME, van Adrichem JC, Rutgers EJ, Rodenhuis S, Linn SC, Loo CE, Gilhuijs KG, Oldenburg HS, Wesseling J, Russell NS, Antonini N, Vrancken Peeters MT. Straver ME, et al. Ned Tijdschr Geneeskd. 2008 Nov 15;152(46):2519-25. Ned Tijdschr Geneeskd. 2008. PMID: 19055260 Dutch.

6

The use of radioactive iodine-125 seed localization in patients with non-palpable breast cancer: a comparison with the radioguided occult lesion localization with 99m technetium.

van der Noordaa ME, Pengel KE, Groen E, van Werkhoven E, Rutgers EJ, Loo CE, Vogel W, Vrancken Peeters MJ. van der Noordaa ME, et al. Eur J Surg Oncol. 2015 Apr;41(4):553-8. doi: 10.1016/j.ejso.2015.01.022. Epub 2015 Feb 3. Eur J Surg Oncol. 2015. PMID: 25707349

7

Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.

Elshof LE, Tryfonidis K, Slaets L, van Leeuwen-Stok AE, Skinner VP, Dif N, Pijnappel RM, Bijker N, Rutgers EJ, Wesseling J. Elshof LE, et al. Eur J Cancer. 2015 Aug;51(12):1497-510. doi: 10.1016/j.ejca.2015.05.008. Epub 2015 May 26. Eur J Cancer. 2015. PMID: 26025767 Free article. Clinical Trial.

8

[Ductal carcinoma in situ: the balance between over- and undertreatment].

Groen EJ, Elshof LE, Rutgers EJ, Winter-Warnars HA, Lips EH, Wesseling J. Groen EJ, et al. Ned Tijdschr Geneeskd. 2016;160:A9773. Ned Tijdschr Geneeskd. 2016. PMID: 27071361 Review. Dutch.

9

Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).

Groen EJ, Elshof LE, Visser LL, Rutgers EJT, Winter-Warnars HAO, Lips EH, Wesseling J. Groen EJ, et al. Among authors: rutgers ejt. Breast. 2017 Feb;31:274-283. doi: 10.1016/j.breast.2016.09.001. Epub 2016 Sep 23. Breast. 2017. PMID: 27671693 Review.

10

Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma In Situ-A Nested Case-Control Study.

Visser LL, Elshof LE, Schaapveld M, van de Vijver K, Groen EJ, Almekinders MM, Bierman C, van Leeuwen FE, Rutgers EJ, Schmidt MK, Lips EH, Wesseling J. Visser LL, et al. Clin Cancer Res. 2018 Aug 1;24(15):3593-3601. doi: 10.1158/1078-0432.CCR-18-0201. Epub 2018 Apr 23. Clin Cancer Res. 2018. PMID: 29685879

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

319 results

Search Page

Filters